Titus Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Titus Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$213K	Buy	+393	New	+$216K	0.11%	149

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Titus Wealth Management's TMO Position: Q2 2022 in Review

Titus Wealth Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2022: 393 shares worth $213K. The stake represents 0.11% of the portfolio and ranks #149 among its holdings.

2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Titus Wealth Management held 393 shares of Thermo Fisher Scientific worth $213K as of Q2 2022.
Thermo Fisher Scientific was a new Titus Wealth Management position in Q2 2022.
Thermo Fisher Scientific made up 0.11% of Titus Wealth Management's portfolio in Q2 2022, its #149 holding.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Titus Wealth Management's 13F filing for Q2 2022, filed 9 Nov 2022.